Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.3%

13 terminated/withdrawn out of 208 trials

Success Rate

89.9%

+3.4% vs industry average

Late-Stage Pipeline

12%

24 trials in Phase 3/4

Results Transparency

9%

10 of 116 completed trials have results

Key Signals

21 recruiting10 with results10 terminated

Enrollment Performance

Analytics

N/A
102(64.6%)
Phase 2
22(13.9%)
Phase 3
12(7.6%)
Phase 4
12(7.6%)
Phase 1
10(6.3%)
158Total
N/A(102)
Phase 2(22)
Phase 3(12)
Phase 4(12)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (208)

Showing 20 of 208 trials
NCT06849596Not ApplicableRecruiting

Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates

Role: collaborator

NCT03920306Phase 4Completed

A Prospective Evaluation of Non-Operative Treatments for Gastrocutaneous Fistulae in Children

Role: collaborator

NCT04198974Not ApplicableActive Not Recruiting

The Canadian Underage Substance Use Prevention Trial

Role: lead

NCT03363217Phase 2Active Not Recruiting

Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.

Role: lead

NCT01655615Not ApplicableCompleted

The Co-Venture Trial: A Cluster Randomized Trial of Personality-targeted Interventions on Adolescent Substance Use and Cognitive Outcomes

Role: lead

NCT04670016Completed

HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers

Role: collaborator

NCT06037083Recruiting

Post-Extubation Assessment of Clinical Stability in ELBW Infants

Role: collaborator

NCT07422766Recruiting

Comparison of Non-Invasive Mean Arterial Blood Pressure Measurements at the Arm and Ankle During Elective Cesarean Delivery.

Role: lead

NCT06666348Phase 1Recruiting

Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

Role: lead

NCT05110456Not ApplicableCompleted

To Evaluate the Effectiveness of a Virtual and Telephone Intervention for the Prevention of Postpartum Depression in Women at Risk

Role: lead

NCT03862950Phase 2Completed

A Trial of Metformin in Individuals With Fragile X Syndrome (Met)

Role: collaborator

NCT04627766Not ApplicableRecruiting

Validation of Continuous Monitoring of Vital Signs in Children With a Connected Patch

Role: lead

NCT00678912Not ApplicableCompleted

Weaning Children From Mechanical Ventilation:Computer-driven System Versus Usual Care

Role: lead

NCT06785272Phase 3Recruiting

Magnesium Trial in Acute Asthma in Emergency Department

Role: collaborator

NCT07187427Not ApplicableNot Yet Recruiting

Incidence of Pruritus Using Intrathecal Fentanyl Versus Epidural Fentanyl to Initiate Labour Analgesia.

Role: lead

NCT03118986Phase 2Recruiting

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Role: collaborator

NCT05026645Enrolling By Invitation

The Medical Management in Patients Exposed to Weapons of Mass Destruction

Role: lead

NCT07173231Not ApplicableNot Yet Recruiting

Use of VR for Diagnostic Hysteroscopy

Role: lead

NCT06182449Not ApplicableNot Yet Recruiting

Virtual Reality Distraction for Maternal Milk Expression (PILOT)

Role: lead

NCT06182462Not ApplicableRecruiting

Virtual Reality Distraction for Dental Anxiety (RCT)

Role: lead